甘肃主产大宗中药材产业链经济效益比较分析  

Comparative Analysis on Economic Benefit of Bulk Medicinal Materials in Gansu Province

作　　者：晋小军[1] 任应宗[1] 晋昕[1] 张欣旸[1] 唐文文[1] 

机构地区：[1]甘肃农业大学农学院,兰州730070

出　　处：《世界科学技术-中医药现代化》2011年第5期800-806,共7页Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology

基　　金：甘肃省农牧厅;财政厅甘肃省中药材产业攻关专项(GYC-09-09):甘肃四种主产道地药材保质储藏技术研究与示范;负责人:晋小军

摘　　要：本文研究分析了甘肃主产大宗中药材在中药产业及不同环节中的经济效益。结果表明,上游中药种植业,虽在主产区种植中药材整体效益高于当地主栽作物和蔬菜,但不同种类药材间差异很大,有进一步优化种植结构,提高效益的空间;中药材加工业效益与药材种类和加工环节长短密切相关。在整个中药产业中,种植业占整个产业利润微小,不足2%;中药材加工增值率最高可达10%左右;在制药环节所占利润近整个产业的90%,其中高端产品增值率能达到90%以上。因此,建议加强中药产业一体化建设,树立产业整体观念,是确保中药产业健康可持续发展的关键。Economic benefit of the bulk medicinal materials in Gansu province was comparative analyzed in the paper.The results of comparative analysis showed that although the general benefit of upstream farming of Chinese Materia Medica（CMM） was higher than vegetables,significant differences exist among various CMM.Further optimization on planting structure is required in the economic benefit increase.In addition,the increasing of efficiency is also related to the time of process and kinds of CMM.The economic benefit of planting only occupies 2% of the entire CMM industry.The highest value-added rate of CMM process is about 10%.The economic benefit from pharmaceutical segment occupies 90% of the total benefit.And the value-added rate of high-end product will be more than 90%.Therefore,construction of industrial integration should be strengthened to ensure the healthy development of pharmaceutical industry.

关 键 词：甘肃 中药产业 中药材 中药经济 

分 类 号：R2-03[医药卫生—中医学]